首页 | 本学科首页   官方微博 | 高级检索  
检索        

蛋白激酶C对低氧猪肺动脉平滑肌细胞结构型一氧化氮合酶mRNA表达作用的探讨
引用本文:丁毅鹏,徐永健,张珍祥.蛋白激酶C对低氧猪肺动脉平滑肌细胞结构型一氧化氮合酶mRNA表达作用的探讨[J].中华结核和呼吸杂志,2001,24(10):588-591.
作者姓名:丁毅鹏  徐永健  张珍祥
作者单位:华中科技大学同济医学院附属同济医院呼吸科
基金项目:国家自然科学基金资助(39770341)原国家教委基金项目(1997-436)和教育部"高等院校骨干教师资助计划”(2000年度)资助
摘    要:目的 探讨蛋白激酶C(PKC)信号传导通道对低氧猪肺动脉平滑肌细胞(PASMC)结构型一氧化氮合酶(cNOS)mRNA表达的影响。方法 采用逆转录-聚合酶链(RT-PCR)方法测定了低氧条件下猪PASMC中PKC-α和cNOS mRNA表达情况,并观察了PKC激活剂和抑制剂对cNOS mRNA表达的影响。结果 低氧48、72h PKC-α mRNA的表达明显升高(P<0.01),cNOS mRNA的表达明显降低(P<0.01),cNOS mRNA的表达与PKC-α mRNA的表达呈显著负相关(P<0.001)。PKC激活剂豆寇酸佛波醇乙酯(PMA)可使cNOS mRNA在低氧PASMC中的表达进一步降低,而KC抑制剂RO 31-8220的作用相反,使cNOS mRNA的表达明显升高(P<0.01)。NO激活剂左旋精氨酸(L-Arg)和抑制剂N^ω-硝基-L-精氨酸甲酯(L-NAME)对PKC-α mRNA的表达无明显影响。结论 PKC可抑制cNOS mRNA在低氧PASMC中的表达。PKC在低氧性肺动脉高压的形成机制中的作用可能是通过抑制cNOS mRNA在PASMC的表达和对NO的调控来实现的,PKC信号通道可能作用在NO的上游,但其机制还有待于进一步的研究。

关 键 词:低氧  肺动脉平滑肌细胞  蛋白激酶C  一氧化氮合酶  mRNA  肺动脉高压
修稿时间:2000年12月27

A study of the effect of protein kinase C on the expression of nitric oxide synthase mRNA in pulmonary artery smooth muscle in hypoxia
DING Yipeng,XU Yongjian,ZHANG Zhenxiang.A study of the effect of protein kinase C on the expression of nitric oxide synthase mRNA in pulmonary artery smooth muscle in hypoxia[J].Chinese Journal of Tuberculosis and Respiratory Diseases,2001,24(10):588-591.
Authors:DING Yipeng  XU Yongjian  ZHANG Zhenxiang
Institution:Department of Respiratory Disease, Tongji Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Abstract:OBJECTIVE: To investigate the effect of PKC on the expression of NOS mRNA in pulmonary artery smooth muscle cell(PASMC) in hypoxia. METHODS: RT-PCR was used to detect the expression of PKC alpha mRNA in PASMC of procine, and the effect of activator and inhibitor of PKC on the expression of cNOS mRNA in PASMC. RESULTS: The expression of PKC-alpha mRNA was higher in the PASMC in 48 and 72 h of hypoxia(P < 0.01), and the expression of cNOS mRNA was lower(P < 0.01). The expression of cNOS mRNA was significantly negatively correlated with the expression of PKC-alpha mRNA(P < 0.001). PMA, an agonist of PKC could reduce the expression of cNOS mNRA in hypoxia, while RO 31-8220, an inhibitor of PKC could inhibit it and enhance the expression of NOS mRNA(P < 0.01). The activator of NO, L-Arg and inhibitor, L-NAME had no effect on expression of PKC-alpha mRNA. CONCLUSION: The PKC can inhibit the expression of cNOS mRNA in PASMC in hypoxia. The effect of PKC in hypoxic pulmonary hypertension may be made by inhibiting the expression of cNOS mRNA and modulating NO. The site of the effect of PKC may be in upstream of NO. The mechanism of it needs to be studied further.
Keywords:Hypoxia  Pulmonary artery  Smooth muscle cell  Protein kinase C  Nitric oxide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号